AI assistant
Sending…
CONMED Corp — Director's Dealing 2025
Mar 5, 2025
31971_dirs_2025-03-05_d60718b9-e4b2-4948-8678-ff4541bf2d24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-03-03
Reporting Person: Lalomia Brent (Vice President QA and RA)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Options To Purchase Common Stock | $58.33 | A | 26895 | Acquired | 2035-03-03 | Common Stock (26895) | Direct |
Footnotes
F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7